
Hoang Vu A. Nguyen Ba
Examiner (ID: 4026, Phone: (571)272-3701 , Office: P/2421 )
| Most Active Art Unit | 2421 |
| Art Unit(s) | 2762, 2421, 2623, 2192, 2122, 2423 |
| Total Applications | 1075 |
| Issued Applications | 880 |
| Pending Applications | 46 |
| Abandoned Applications | 152 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19752892
[patent_doc_number] => 20250041457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-06
[patent_title] => USE OF ADENO-ASSOCIATED VIRAL VECTORS TO CORRECT GENE DEFECTS/ EXPRESS PROTEINS IN HAIR CELLS AND SUPPORTING CELLS IN THE INNER EAR
[patent_app_type] => utility
[patent_app_number] => 18/806641
[patent_app_country] => US
[patent_app_date] => 2024-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 107057
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18806641
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/806641 | USE OF ADENO-ASSOCIATED VIRAL VECTORS TO CORRECT GENE DEFECTS/ EXPRESS PROTEINS IN HAIR CELLS AND SUPPORTING CELLS IN THE INNER EAR | Aug 14, 2024 | Pending |
Array
(
[id] => 19541728
[patent_doc_number] => 20240358764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-31
[patent_title] => NEURONAL REGENERATION PROMOTING CELLS (NRPCs) AND TREATING DAMAGED NERVE CELLS
[patent_app_type] => utility
[patent_app_number] => 18/589244
[patent_app_country] => US
[patent_app_date] => 2024-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23671
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18589244
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/589244 | NEURONAL REGENERATION PROMOTING CELLS (NRPCs) AND TREATING DAMAGED NERVE CELLS | Feb 26, 2024 | Abandoned |
Array
(
[id] => 19921100
[patent_doc_number] => 12295355
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-13
[patent_title] => Kit for breeding a TGEV infection resistant pig and use thereof
[patent_app_type] => utility
[patent_app_number] => 18/409695
[patent_app_country] => US
[patent_app_date] => 2024-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 11
[patent_no_of_words] => 920
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18409695
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/409695 | Kit for breeding a TGEV infection resistant pig and use thereof | Jan 9, 2024 | Issued |
Array
(
[id] => 20527472
[patent_doc_number] => 12545898
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-02-10
[patent_title] => Efficient and non-genetically modified iPSC-induced, industrialized single clone selection platform, and use
[patent_app_type] => utility
[patent_app_number] => 18/512843
[patent_app_country] => US
[patent_app_date] => 2023-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 3631
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 343
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18512843
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/512843 | Efficient and non-genetically modified iPSC-induced, industrialized single clone selection platform, and use | Nov 16, 2023 | Issued |
Array
(
[id] => 19300405
[patent_doc_number] => 20240228974
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2024-07-11
[patent_title] => VASCULARIZED ISLET AND PREPARATION METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/381660
[patent_app_country] => US
[patent_app_date] => 2023-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3225
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 232
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18381660
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/381660 | VASCULARIZED ISLET AND PREPARATION METHOD THEREOF | Oct 18, 2023 | Abandoned |
Array
(
[id] => 19300405
[patent_doc_number] => 20240228974
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2024-07-11
[patent_title] => VASCULARIZED ISLET AND PREPARATION METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/381660
[patent_app_country] => US
[patent_app_date] => 2023-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3225
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 232
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18381660
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/381660 | VASCULARIZED ISLET AND PREPARATION METHOD THEREOF | Oct 17, 2023 | Abandoned |
Array
(
[id] => 18786376
[patent_doc_number] => 20230374463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => DEGENERATING OVARIAN MICROENVIRONMENT RESISTANT MESENCHYMAL STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 18/311768
[patent_app_country] => US
[patent_app_date] => 2023-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8911
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18311768
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/311768 | DEGENERATING OVARIAN MICROENVIRONMENT RESISTANT MESENCHYMAL STEM CELLS | May 2, 2023 | Pending |
Array
(
[id] => 18597543
[patent_doc_number] => 20230272339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => COMPOSITIONS AND METHODS FOR CELLULAR COMPONENT TRANSFER THERAPY
[patent_app_type] => utility
[patent_app_number] => 18/310048
[patent_app_country] => US
[patent_app_date] => 2023-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10872
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18310048
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/310048 | COMPOSITIONS AND METHODS FOR CELLULAR COMPONENT TRANSFER THERAPY | Apr 30, 2023 | Pending |
Array
(
[id] => 19543404
[patent_doc_number] => 20240360440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-31
[patent_title] => Bos GRUNNIENSLNC4047 AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/140060
[patent_app_country] => US
[patent_app_date] => 2023-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2777
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18140060
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/140060 | Bos GRUNNIENSLNC4047 AND APPLICATION THEREOF | Apr 26, 2023 | Pending |
Array
(
[id] => 18692947
[patent_doc_number] => 20230323306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => JAMMED GEL BIOINK WITH SELF-ASSEMBLING PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 18/296168
[patent_app_country] => US
[patent_app_date] => 2023-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3253
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18296168
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/296168 | JAMMED GEL BIOINK WITH SELF-ASSEMBLING PEPTIDES | Apr 4, 2023 | Pending |
Array
(
[id] => 19297615
[patent_doc_number] => 20240226181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => HUMAN UMBILICAL CORD COMPOSITION FOR TREATMENT OF PEYRONIE'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/130555
[patent_app_country] => US
[patent_app_date] => 2023-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8164
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18130555
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/130555 | HUMAN UMBILICAL CORD COMPOSITION FOR TREATMENT OF PEYRONIE'S DISEASE | Apr 3, 2023 | Pending |
Array
(
[id] => 18649749
[patent_doc_number] => 20230295569
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => THERAPEUTIC REGENERATIVE CELLS
[patent_app_type] => utility
[patent_app_number] => 18/183900
[patent_app_country] => US
[patent_app_date] => 2023-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 115847
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18183900
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/183900 | THERAPEUTIC REGENERATIVE CELLS | Mar 13, 2023 | Pending |
Array
(
[id] => 18692937
[patent_doc_number] => 20230323295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => PRODUCTION METHOD FOR MICROGLIA
[patent_app_type] => utility
[patent_app_number] => 18/176959
[patent_app_country] => US
[patent_app_date] => 2023-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6490
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18176959
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/176959 | PRODUCTION METHOD FOR MICROGLIA | Feb 28, 2023 | Pending |
Array
(
[id] => 18334620
[patent_doc_number] => 20230126568
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => PRODUCTION METHOD FOR INTESTINAL EPITHELIAL CELLS AND UTILIZATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/146198
[patent_app_country] => US
[patent_app_date] => 2022-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16444
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18146198
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/146198 | PRODUCTION METHOD FOR INTESTINAL EPITHELIAL CELLS AND UTILIZATION THEREOF | Dec 22, 2022 | Abandoned |
Array
(
[id] => 18420477
[patent_doc_number] => 20230174939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => NOVEL ANUCLEATED CELLS AS A SOURCE FOR TREATMENT OF PLATELET RICH PLASMA DEPENDENT DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/985365
[patent_app_country] => US
[patent_app_date] => 2022-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16877
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17985365
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/985365 | NOVEL ANUCLEATED CELLS AS A SOURCE FOR TREATMENT OF PLATELET RICH PLASMA DEPENDENT DISORDERS | Nov 10, 2022 | Pending |
Array
(
[id] => 18389931
[patent_doc_number] => 20230158149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => Wafer-Scale Protein Patterning of Hydrogel Devices
[patent_app_type] => utility
[patent_app_number] => 17/972306
[patent_app_country] => US
[patent_app_date] => 2022-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12283
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17972306
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/972306 | Wafer-Scale Protein Patterning of Hydrogel Devices | Oct 23, 2022 | Pending |
Array
(
[id] => 18565694
[patent_doc_number] => 20230256021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => COMPOSITIONS FOR PREVENTING OR TREATING DIABETIC SKIN DISEASE COMPRISING EXOSOME-DERIVED FROM THROMBIN-TREATED STEM CELL
[patent_app_type] => utility
[patent_app_number] => 17/965656
[patent_app_country] => US
[patent_app_date] => 2022-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4567
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17965656
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/965656 | COMPOSITIONS FOR PREVENTING OR TREATING DIABETIC SKIN DISEASE COMPRISING EXOSOME-DERIVED FROM THROMBIN-TREATED STEM CELL | Oct 12, 2022 | Pending |
Array
(
[id] => 18211694
[patent_doc_number] => 20230057957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => UMBILICAL CORD MESENCHYMAL STEM CELLS FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND LUNG DEGENERATION
[patent_app_type] => utility
[patent_app_number] => 17/821754
[patent_app_country] => US
[patent_app_date] => 2022-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10818
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17821754
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/821754 | UMBILICAL CORD MESENCHYMAL STEM CELLS FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND LUNG DEGENERATION | Aug 22, 2022 | Abandoned |
Array
(
[id] => 18421577
[patent_doc_number] => 20230176040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => ANASTASIS BIOSENSOR
[patent_app_type] => utility
[patent_app_number] => 17/854989
[patent_app_country] => US
[patent_app_date] => 2022-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16134
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17854989
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/854989 | ANASTASIS BIOSENSOR | Jun 29, 2022 | Abandoned |
Array
(
[id] => 18253226
[patent_doc_number] => 20230080265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => HUMANIZED MOUSE MODELS FOR STUDY OF COVID-19
[patent_app_type] => utility
[patent_app_number] => 17/850770
[patent_app_country] => US
[patent_app_date] => 2022-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14570
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17850770
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/850770 | HUMANIZED MOUSE MODELS FOR STUDY OF COVID-19 | Jun 26, 2022 | Abandoned |